Hepatocellular carcinoma (HCC) is one of the most common solid malignancies worldwide.
A large proportion of patients with HCC are diagnosed at advanced stages and are only …

Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC
develops in genetically susceptible individuals who are exposed to risk factors, especially in …

Immunotherapy has emerged as an effective treatment for various types of cancers. Recent
studies have highlighted a significant correlation between the gut microbiome and patients' …

The role of the tumor microenvironment (TME) in the progression of colorectal cancer (CRC)
and its acquisition of resistance to treatment become the research hotspots. As an important …

With the recent availability and upgrading of many emerging intestinal microbes sequencing
technologies, our research on intestinal microbes is changing rapidly. A variety of …

The recent evolution of immunotherapy has revolutionised the treatment of hepatocellular
carcinoma (HCC) and has led to new therapeutic standards. The advances in …

The liver is frequently exposed to potentially toxic materials, and it is the primary site of
clearance of foreign agents, along with many innate and adaptive immune cells …

Fecal samples from participants aged 60–80 were collected and sequenced by a high-
throughput second-generation sequencer to explore the structural composition of gut …

Hepatocellular carcinoma (HCC) is the most common malignancy of the liver, posing a
significant threat to public health. Although liver transplantation (LT) is an effective treatment …

Liver is an important organ in body that performs vital functions such as detoxification. Liver
is susceptible to development of cancers, and hepatocellular carcinoma (HCC) is among …